These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18492905)

  • 21. Contrast harmonic sonographically guided radio frequency ablation for spontaneous ruptured hepatocellular carcinoma.
    Tamai H; Oka M; Maeda H; Shingaki N; Kanno T; Enomoto S; Shiraki T; Iguchi M; Nakazawa K; Arii K; Yanaoka K; Shimizu Y; Nakata H; Fujishiro M; Yahagi N; Shiina S; Ichinose M
    J Ultrasound Med; 2005 Jul; 24(7):1021-6. PubMed ID: 15972719
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated?
    Kim YJ; Raman SS; Yu NC; Busuttil RW; Tong M; Lu DS
    AJR Am J Roentgenol; 2008 Apr; 190(4):1029-34. PubMed ID: 18356451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
    Widmann G; Schullian P; Haidu M; Bale R
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous radiofrequency ablation of hepatocellular carcinomas: factors related to intraprocedural and postprocedural pain.
    Lee S; Rhim H; Kim YS; Choi D; Lee WJ; Lim HK; Shin B
    AJR Am J Roentgenol; 2009 Apr; 192(4):1064-70. PubMed ID: 19304715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours.
    Kwan J; Appuhamy C; Lim GHT; Huang IKH; Quek L; Pua U
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):920-927. PubMed ID: 29582128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Inoue T; Sakaguchi Y; Sakamoto H; Shiozaki H
    J Gastroenterol; 2003; 38(11):1066-70. PubMed ID: 14673724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technical report: Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma.
    Gandhi S; Iannitti DA; Mayo-Smith WW; Dupuy DE
    Clin Radiol; 2006 Oct; 61(10):888-91. PubMed ID: 16978986
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma.
    Rossi S; Di Stasi M; Buscarini E; Cavanna L; Quaretti P; Squassante E; Garbagnati F; Buscarini L
    Cancer J Sci Am; 1995; 1(1):73-81. PubMed ID: 9166457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of laparoscopic radiofrequency ablation of hepatocellular carcinoma.
    Okabayashi T; Kobayashi M; Akimori T; Akisawa N; Iwasaki S; Onishi S; Araki K
    Surg Technol Int; 2005; 14():177-81. PubMed ID: 16525971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm.
    Koda M; Ueki M; Maeda Y; Mimura K; Okamoto K; Matsunaga Y; Kawakami M; Hosho K; Murawaki Y
    AJR Am J Roentgenol; 2004 Sep; 183(3):583-8. PubMed ID: 15333339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
    Ayav A; Germain A; Marchal F; Tierris I; Laurent V; Bazin C; Yuan Y; Robert L; Brunaud L; Bresler L
    Am J Surg; 2010 Oct; 200(4):435-9. PubMed ID: 20409524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma.
    Lin SM; Lin CJ; Chung HJ; Hsu CW; Peng CY
    AJR Am J Roentgenol; 2003 Jan; 180(1):151-7. PubMed ID: 12490494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels.
    Thanos L; Mylona S; Galani P; Pomoni M; Pomoni A; Koskinas I
    Diagn Interv Radiol; 2008 Mar; 14(1):51-6. PubMed ID: 18306146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.